Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Fresenius Medical Care Ag ADR
(NY:
FMS
)
19.45
+0.45 (+2.37%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Fresenius Medical Care Ag ADR
< Previous
1
2
3
Next >
Current Analysis: Fresenius Medical Care (FMS)
August 12, 2024
Fresenius Medical Care (FMS) is the largest dialysis company in the world. Over the past year, Fresenius's share price fell just over 30% from $26.09 to $18.14 as of Monday’s market close.
Via
Talk Markets
Why Merck Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
July 30, 2024
Via
Benzinga
Lattice Semiconductor Posts Weak Q2 Results, Joins Symbotic, Woodward And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
July 30, 2024
Via
Benzinga
Fresenius Medical Care: Q4 Earnings Insights
February 20, 2024
Via
Benzinga
A Preview Of Fresenius Medical Care's Earnings
February 19, 2024
Via
Benzinga
Stock Analysis: Fresenius Medical Care
June 18, 2024
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022.
Via
Talk Markets
Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway
June 11, 2024
You can't go wrong by following in the Oracle's footsteps and buying these cheap Buffett stocks before the market catches on.
Via
InvestorPlace
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
May 17, 2024
Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and...
Via
Benzinga
Current Analysis: Fresenius Medical Care
May 15, 2024
Fresenius Medical Care is the largest dialysis company in the world and a leading supplier of dialysis products, including machines, dialyzers, and concentrates.
Via
Talk Markets
Topics
Supply Chain
Exposures
Supply Chain
FMS Stock Earnings: Fresenius Medical Care Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
FMS stock results show that Fresenius Medical Care beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
May 07, 2024
Via
Benzinga
AudioCodes Reports Downbeat Earnings, Joins Trupanion, Palantir Technologies And Other Big Stocks Moving Lower In Tuesday Pre-Market Session
May 07, 2024
Via
Benzinga
Matterport, Sea Limited, Ingevity And Other Big Stocks Moving Higher On Monday
April 22, 2024
Via
Benzinga
Why Are Dialysis Provider Stocks Trading Higher On Tuesday?
March 05, 2024
Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks
Via
Benzinga
Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
March 05, 2024
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.
Via
Benzinga
NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday
March 05, 2024
U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News
March 05, 2024
Novo Nordisk tested its diabetes and weight-loss drug in patients with chronic kidney disease.
Via
Investor's Business Daily
Stock Market Whiplash
February 24, 2024
We've also got a look at the international real estate market.
Via
The Motley Fool
Dialysis Player Fresenius Medical's Q4 Sales Hold Steady: Details
February 20, 2024
Fresenius Medical Care Q4 2023 revenue: €4.9 billion. Patient volume growth is expected at 0.5%-2% in 2024.
Via
Benzinga
Fresenius Medical Care Hit By Major Data Breach: Half A Million Patients Potentially Affected
December 06, 2023
Fresenius Medical Care (NYSE: FMS) said in a
Via
Benzinga
Only Have $100? 3 No-Brainer Stocks to Buy Right Now
November 28, 2023
The stock market is such a well-oiled, wealth-generating machine that investors can start with just $100 to buy these no-brainer stocks.
Via
InvestorPlace
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
October 27, 2023
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.
Via
Investor's Business Daily
Earnings Scheduled For February 20, 2024
February 20, 2024
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.
Via
Benzinga
Stock Market Rallies, Hits Resistance; Novo Nordisk, JPMorgan, Exxon In Focus: Weekly Review
October 13, 2023
The major indexes stalled at key levels amid weak breadth.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's Intraday Session
October 11, 2023
Via
Benzinga
Why Dialysis Stocks Plunged Today
October 11, 2023
Novo Nordisk indicated one of its diabetes drugs could also be used to treat kidney disease. Here's what investors need to know.
Via
The Motley Fool
Why Shares of Fresenius Medical Care Were Dropping on Wednesday
October 11, 2023
Positive trial news for a kidney failure drug could cut into business for dialysis therapies companies such as Fresenius.
Via
The Motley Fool
What's Going On With Kidney Dialysis Provider Stocks Today?
October 11, 2023
DaVita Inc (NYSE: DVA), Fresenius Medical Care AG (NYSE: FMS), and Baxter International Inc (NYSE: BAX) shares fel
Via
Benzinga
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
October 11, 2023
Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in...
Via
Benzinga
Ozempic Is Moving a Bunch of Stocks Wednesday Morning
October 11, 2023
Find out who the winners and losers are.
Via
The Motley Fool
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.